Publications by authors named "Deborah Hartman"

Claim this Profile
O
Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individuals.
Rebecca Evans, Haruhide Kimura, Masato Nakashima, Takashi Ishikawa, Hiroshi Yukitake, Deborah S Hartman

J Sleep Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Genotype to Phenotype-A Review of Kabuki Syndrome.
Kelly K Barry, Michaelangelo Tsaparlis, Deborah Hoffman, Deborah Hartman, Margaret P Adam

Genes (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients.
Rebecca Evans, Haruhide Kimura, Robert Alexander, Ceri H Davies, Hélène Faessel, Deborah S Hartman

Proc Natl Acad Sci U S A· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Qualitative Study to Characterize the Humanistic Burden of Kabuki Syndrome in the United States and Canada.
Christina Theodore-Oklota, Deborah S Hartman, Deborah L Hoffman, Hans T Björnsson

Adv Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics and pharmacodynamics of TAK-418, a novel inhibitor of the epigenetic modulator lysine-specific demethylase 1A.
Wei Yin, Dimitrios Arkilo, Polyna Khudyakov, Jim Hazel, Saurabh Gupta, Deborah S Hartman

Br J Clin Pharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural features of bovine colostral immunoglobulin that confer proteolytic stability in a simulated intestinal fluid.
Randall E Burton, Skaison Kim, Rutvij Patel, Deborah S Hartman, Daniel E Tracey

J Biol Chem· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caregiver-reported clinical characteristics and the burden associated with Kabuki syndrome.
Christina Theodore-Oklota, Shayna Egan, Maggie Paulich, Christopher J Evans, Deborah S Hartman

Am J Med Genet A· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative Colitis.
Deborah S Hartman, Daniel E Tracey, Brenda R Lemos, Emma C Erlich, Randall E Burton

J Crohns Colitis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial.
M Scott Harris, Deborah Hartman, Brenda R Lemos, Emma C Erlich, Sharon Spence

J Crohns Colitis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum and colostral antibody production in cows immunized with recombinant human tumor necrosis factor.
Randall Burton, Skaison Kim, Rutvij Patel, Michele Scola, Deborah Hartman

J Dairy Sci· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes and graft characteristics in pediatric matched sibling donor transplants using granulocyte colony-stimulating factor-primed bone marrow and steady-state bone marrow.
Kuang-Yueh Chiang, Ann Haight, John Horan, Ellen Olson, Amy Gartner, Deborah Hartman

Pediatr Transplant· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An immobilized metal ion affinity adsorption and scintillation proximity assay for receptor-stimulated phosphoinositide hydrolysis.
Jay Jie Liu, Deborah S Hartman, James Robert Bostwick

Anal Biochem· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RO-10-5824 is a selective dopamine D4 receptor agonist that increases novel object exploration in C57 mice.
Susan B Powell, Martin P Paulus, Deborah S Hartman, Thierry Godel, Mark A Geyer

Neuropharmacology· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis